Literature DB >> 102330

Coronary and myocardial metabolic effects of combined glyceryl trinitrate and propranolol administration. Observations in patients with and without coronary disease.

S J Schang, C J Pepine.   

Abstract

Coronary haemodynamic and metabolic effects of propranolol and glyceryl trinitrate were studied in 12 patients with coronary artery disease and 5 without coronary heart disease, at rest and during tachycardia stress. Propranolol-associated reductions in indices of myocardial oxygen demand, left ventricle work, tension time, and left ventricle oxygen utilisation (LVVO2) were reversed when heart rate was controlled by atrial pacing. Adding glyceryl trinitrate at rest also restored heart rate but decreased the left ventricular work index and tension time index as coronary resistance declined paradoxically. Tachycardia-related increases in tension time index and LVVO2 were unchanged after propranolol, and ischaemia (angina, ST depression, and reduced lactate extraction) was not altered in most of the patients. During tachycardia, the addition of glyceryl trinitrate decreased the tension time index and LVVO2; angina recurred in only 4 patients, and ST depression and lactate extraction improved. Similar haemodynamic changes occurred in the patients with normal coronary arteries. In contrast with propranolol administered alone, propranolol plus glyceryl trinitrate enhances tachycardia tolerance and prevents tachycardia-induced manifestations of ischaemia. This action is attributed to glyceryl trinitrate-associated improvement in the adequacy of myocardial perfusion.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 102330      PMCID: PMC483555          DOI: 10.1136/hrt.40.11.1221

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  23 in total

1.  BLOCKAGE OF SYMPATHETIC BETA-RECEPTORS IN THE MYOCARDIAL CIRCULATION.

Authors:  J R PARRATT
Journal:  Br J Pharmacol Chemother       Date:  1965-06

2.  Effect of nitroglycerin on the coronary circulation in patients with coronary artery disease or increased left ventricular work.

Authors:  R GORLIN; N BRACHFELD; C MACLEOD; P BOPP
Journal:  Circulation       Date:  1959-05       Impact factor: 29.690

3.  Propranolol in the treatment of acute myocardial infarction. Effect on myocardial oxygenation and hemodynamics.

Authors:  H S Mueller; S M Ayres; A Religa; R G Evans
Journal:  Circulation       Date:  1974-06       Impact factor: 29.690

Review 4.  Medical management of patients with angina pectoris.

Authors:  R E Goldstein; S E Epstein
Journal:  Prog Cardiovasc Dis       Date:  1972-01       Impact factor: 8.194

5.  Mechanism of the decrease in coronary blood flow after beta-blockade in conscious dogs.

Authors:  G Marchetti; L Merlo; V Noseda
Journal:  Cardiovasc Res       Date:  1972-09       Impact factor: 10.787

6.  Effects of perhexiline on coronary hemodynamic and myocardial metabolic responses to tachycardia.

Authors:  C J Pepine; S J Schang; C R Bemiller
Journal:  Circulation       Date:  1974-05       Impact factor: 29.690

7.  Effect of propranolol on myocardial oxygen consumption and its hemodynamic correlates during upright exercise.

Authors:  C R Jorgensen; K Wang; Y Wang; F L Gobel; R R Nelson; H Taylor
Journal:  Circulation       Date:  1973-12       Impact factor: 29.690

8.  Ischemic response to sudden strenuous exercise in healthy men.

Authors:  R J Barnard; R MacAlpin; A A Kattus; G D Buckberg
Journal:  Circulation       Date:  1973-11       Impact factor: 29.690

9.  Medical treatment of angina pectoris. 3. Pharmacology of sublingual nitrites as antianginal drugs.

Authors:  W S Aronow
Journal:  Am Heart J       Date:  1972-08       Impact factor: 4.749

10.  Quantitative evaluation of coronary perfusion in man.

Authors:  F J Klocke
Journal:  Cathet Cardiovasc Diagn       Date:  1975
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.